Baihua Pharmaceutical: pengendali aktual akan berubah menjadi Komite Pengawas Aset Negara Kota Jinhua, saham mulai diperdagangkan lagi mulai besok

Reuters 7 April 2026, BAIHUA PHARMACEUTICAL (600721) 7 April announced, the company’s controlling shareholder and actual controller, Mi Zaiqi, Mi Enhua, Yang Xiaoling, and Jinhua Juixin Enterprise Management Partnership (Limited Partnership) (hereinafter referred to as “Jinhua Juixin”) signed a “Share Transfer Agreement”, intending to transfer, by agreement, the 79.5251 million shares of the company’s unrestricted tradable shares they collectively hold (accounting for 20.68% of the company’s total shares) (hereinafter referred to as “Subject Shares”), as well as all shareholder rights that the company’s articles of association and the laws of China provide for shareholders to enjoy, including the profit distribution rights, voting rights, director nomination rights, asset distribution rights corresponding to the Subject Shares, to Jinhua Juixin; Jinhua Juixin accepts such transfer. The total consideration for the Subject Shares transfer in this transaction is 890 million yuan, equivalent to 11.19 yuan per share. After this transaction is completed, the company’s controlling shareholder will be changed to Jinhua Juixin, and the actual controller will be changed to the State-owned Assets Supervision and Administration Commission of Jinhua People’s Government. After the company applies to the Shanghai Stock Exchange, the company’s shares will resume trading from the opening of trading on 8 April 2026.